Wound Closure Study in Carpal Tunnel and Trigger Finger Surgery
Launched by MAYO CLINIC · Dec 17, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of stitches affect patient satisfaction and the appearance of scars after surgeries for carpal tunnel syndrome and trigger finger. Specifically, it compares absorbable stitches, which dissolve over time, to non-absorbable stitches, which need to be removed later. The goal is to find out if one type is better than the other in terms of how happy patients feel about their surgery results and how their wounds look.
To participate in this study, you need to be at least 18 years old and be scheduled for your first surgery to relieve carpal tunnel syndrome or trigger finger. People who have had previous surgeries on the same hand or finger, or certain other hand conditions, won’t be eligible. If you join the trial, you can expect regular check-ins after your surgery to discuss your recovery and how you feel about the results. This study is currently recruiting participants, so if you think you might be interested, it could be a great opportunity to help improve surgical outcomes for future patients!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patient greater than or equal to 18 years of age.
- • Any patient undergoing primary open carpal tunnel release or primary trigger finger pulley release
- Exclusion Criteria:
- • Any patient identified outside of the proposed study time period.
- • Any patient receiving revision surgery
- • Patients who have had prior ipsilateral palmar or finger surgery
- • Patients with Dupuytren's disease
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Peter C Rhee
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials